Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

Question 2

How does JMT101 combined with Osimertinib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

Question 6

What support is available if I decide to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer clinical trial (NCT05132777). Contact the study team or your healthcare provider for specific answers.

What this study is about